Answer
After every dose in the Tecvayli (teclistamab) step-up dosing schedule, including the first maintenance dose, patients should remain near a healthcare facility and be monitored daily for 48 hours for signs and symptoms of cytokine release syndrome.
Sources for this answer
- TECVAYLI 90mg/ml solution for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.2 Posology and method of administration · Version 11Document updated
Sources checked